Nanomerics is a speciality pharmaceutical company focused on the development of pharmaceutical products with enhanced bioavailability. The company uses proprietary pharmaceutical nanotechnology and know-how developed by the founding scientists Professor Ijeoma F. Uchegbu and Dr Andreas G. Schatzlein over the last 14 years at the Universities of Strathclyde and Glasgow and, latterly at the UCL School of Pharmacy. Our scientists have been developing drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. At the heart of the company's offering are polymer based nanomedicines constructed from the self-assembly of amphiphilic polymers and dendrimers.